• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Target Offers Team Members Free Access to Virtual Visits Via CirrusMD

Share:

June 23, 2020

Target today announced a number of industry-leading updates and extensions to its pay and benefits including access to virtual care visits. To support the health and safety of its team members during a stressful year for the country, Target will also offer free access to health care through virtual doctor visits, regardless of whether team members currently subscribe to a Target health care plan.

Extended COVID-19 Benefits

The offering is through the CirrusMD app and focuses on text-first virtual health care visits for team members to securely text, share images or video chat with a doctor. The platform will be available 24 hours a day, 7 days a week at no extra cost to U.S.-based team members until the end of December 2020, so they can conveniently and safely seek medical advice at a time of heightened focus on health and well-being.

Connecting Patients to Doctors in Seconds

Founded in 2012 by Blake McKinney, an emergency physician realized the transformative role of telemedicine fueled by his own frustrating experiences in the emergency department. CirrusMD partners with health plans to build greater trust in member populations and deliver exceptional virtual care experiences by breaking through the barriers that exist in today’s traditional healthcare landscape.

Break Barriers Not Trust

Members can access unlimited, on-demand dialogue with a board-certified physician across 50 states in seconds via the web or mobile app, whenever and wherever it fits in their day. There are no paywall barriers, and physician conversation can last as long as members need to get the answers – and peace of mind – to manage their wellness. The platform empowers better care access, reduces unnecessary Emergency Room visits, decreases wait times and lowers call center volume while driving member utilization rates that exceed telehealth industry norms by nearly three times.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Source: HIT Consultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Merck Completes Acquisition of Prometheus Biosciences, Inc.Merck Completes Acquisition of Prometheus Biosciences, Inc.
  • WithMe Health Scores $20M to Support Growth, Sofía Raises $19M for Product Development and More Digital Health FundingsWithMe Health Scores $20M to Support Growth, Sofía Raises $19M for Product Development and More Digital Health Fundings
  • Well Health Nabs $45M to Expand Intelligent Communications HubWell Health Nabs $45M to Expand Intelligent Communications Hub
  • Moderna, IBM Partner on COVID-19 Vaccine Supply Chain & Distribution Data SharingModerna, IBM Partner on COVID-19 Vaccine Supply Chain & Distribution Data Sharing
  • Medidata Launches New Tech to Transform the Patient Clinical Trial ExperienceMedidata Launches New Tech to Transform the Patient Clinical Trial Experience
  • WuXi STA to Purchase Bristol Myers Squibb Manufacturing Facility in Couvet, SwitzerlandWuXi STA to Purchase Bristol Myers Squibb Manufacturing Facility in Couvet, Switzerland
  • Intuition Robotics Musters $36M Series B for Its Assorted AI CompanionsIntuition Robotics Musters $36M Series B for Its Assorted AI Companions
  • PainChek Partners with Ward MM to Roll out National Trial of Pain Assessment SoftwarePainChek Partners with Ward MM to Roll out National Trial of Pain Assessment Software

Trending This Week

  • Novartis Drops Eye Disease Gene Therapy from $800M Gyroscope Acquisition
  • GSAC Engineering Acquires Key Intellectual Property and Assets from Duos Technologies GroupGelStat’s Subsidiary, GSAC Engineering, Launches Intelligent Correctional Facilities Automation Systems (iCAS) in the Industrial Security Market
  • Life Launches AI Clinical Trial Matching Assistant for Cancer
  • 79% of Healthcare Execs Believe Most Drug Diversion Goes Undetected
  • Moonshot Client Axolotl Announces Merger with Carmell Therapeutics, Elevating the Field of Regenerative Medicine
  • FDA Releases Updated Final Guidance for its Breakthrough Devices Program

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications